tiprankstipranks
Cytokinetics (CYTK)
NASDAQ:CYTK
Holding CYTK?
Track your performance easily

Cytokinetics (CYTK) Technical Analysis

996 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
3Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Cytokinetics’s (CYTK) Moving Averages Convergence Divergence (MACD) indicator is -0.92, suggesting Cytokinetics is a Buy.
Cytokinetics’s (CYTK) 20-Day exponential moving average is 52.78, while Cytokinetics’s (CYTK) share price is $49.42, making it a Sell.
Cytokinetics’s (CYTK) 50-Day exponential moving average is 53.71, while Cytokinetics’s (CYTK) share price is $49.42, making it a Sell.

Cytokinetics (CYTK) Pivot Points

Nov 22, 2024, 03:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
48.06
48.85
49.36
50.15
50.66
51.45
51.96
Fibonacci
48.85
49.35
49.66
50.15
50.65
50.96
51.45
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cytokinetics (CYTK) Moving Averages

Nov 22, 2024, 03:16 PM
Period
Simple
Exponential
MA5
50.16Sell
50.31Sell
MA10
53.42Sell
51.82Sell
MA20
52.94Sell
52.78Sell
MA50
53.74Sell
53.71Sell
MA100
54.95Sell
55.01Sell
MA200
59.53Sell
58.73Sell
Cytokinetics’s (CYTK) 10-Day exponential moving average is 51.82, while Cytokinetics’s (CYTK) share price is $49.42, making it a Sell.
Cytokinetics’s (CYTK) 100-Day exponential moving average is 55.01, while Cytokinetics’s (CYTK) share price is $49.42, making it a Sell.
Cytokinetics’s (CYTK) stock price is $49.42 and Cytokinetics’s (CYTK) 50-day simple moving average is 53.74, creating a Sell signal.
Cytokinetics’s (CYTK) stock price is $49.42 and Cytokinetics’s (CYTK) 100-day simple moving average is 54.95, creating a Sell signal.
Cytokinetics’s (CYTK) stock price is $49.42 and Cytokinetics’s (CYTK) 200-day simple moving average is 59.53, creating a Sell signal.

Cytokinetics (CYTK) Technical Indicators

Nov 22, 2024, 03:16 PM
Name
Value
Implied Action
RSI (14)
34.51
Neutral
STOCH (9,6)
6.02
Buy
STOCHRSI (14)
6.02
Buy
MACD (12,26)
-0.92
Buy
ADX (14)
21.14
Neutral
Williams %R
-99.07
Buy
CCI (14)
-126.45
Buy
ATR (14)
2.20
-
Ultimate Oscillator
32.04
Neutral
ROC
-8.01
Sell
Cytokinetics’s (CYTK) Relative Strength Index (RSI) is 34.51, creating a Neutral signal.
Cytokinetics’s (CYTK) Trend Strength Indicator (ADX) is 21.14, creating a Neutral signal.
Cytokinetics’s (CYTK) Commodity Channel Index (CCI) is -126.45, creating a Buy signal.
Cytokinetics’s (CYTK) Price Rate of Change (ROC) is -8.01, creating a Sell signal.

FAQ

Is CYTK a Buy, Hold, or Sell?
Based on CYTK’s technical indicators, CYTK is a Sell.
    What is CYTK’s RSI (14)?
    CYTK’s RSI (14) is 34.51, which suggests CYTK is a Neutral.
      What is CYTK’s MACD?
      CYTK’s MACD is -0.92, which suggests CYTK is a Buy.
        What is CYTK’s 5-day moving average?
        CYTK’s 5-day moving average is 50.16, which suggests CYTK is a Sell.
          What is CYTK’s 20-day moving average?
          CYTK 20-day moving average is 52.94, which suggests CYTK is a Sell.
            What is CYTK’s 50-day moving average?
            CYTK’s 50-day moving average is 53.74, which suggests CYTK is a Sell.
              What is CYTK’s 200-day moving average?
              CYTK’s 200-day moving average is 59.53, which suggests CYTK is a Sell.
                What is CYTK’s Williams % R (14)?
                CYTK’s Williams % R (14) is -99.07, which suggests CYTK is a Buy.
                  What is CYTK’s CCI (14)?
                  CYTK’s CCI (14) is -126.45, which suggests CYTK is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis